Istaroxime in Heart Failure. New Hope or More Hype**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Journal of the American College of Cardiology

Volumn 51, Issue 23, 2008, Pages 2286-2288

  Dec, G William ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM MYOSIN ACTIVATOR; DOBUTAMINE; INOTROPIC AGENT; ISTAROXIME; LEVOSIMENDAN; MILRINONE;

CLINICAL TRIAL; DOPPLER ECHOGRAPHY; DRUG MECHANISM; EDITORIAL; HEART ARRHYTHMIA; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART RATE; HUMAN; HYPOTENSION; INOTROPISM; MORTALITY; NONHUMAN; PRIORITY JOURNAL;

ACUTE DISEASE; CARDIOTONIC AGENTS; ETIOCHOLANOLONE; HEART FAILURE; HEART RATE; HUMANS; STROKE VOLUME;

EID: 44449135982     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.04.005     Document Type: Editorial

References (14)

1. Abraham W.T., Adams K.F., Fonarow G.C., et al., ADHERE Scientific Advisory Committee and Investigators, ADHERE Study Group. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications. An analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol 46 (2005) 57-64
2. Mehra M.R. Optimizing outcomes in the patient with acute decompensated heart failure. Am Heart J 151 (2006) 571-579
3. Fonarow G.C., Adams K.F., Abraham W.T., et al. Risk stratification for in-hospital mortality in acute decompensated heart failure: classification and regression tree analysis. JAMA 293 (2005) 572-580
4. Felker G.M., Benza R.L., Chandler A.B., et al. Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study. J Am Coll Cardiol 41 (2003) 997-1003
5. deGoma E.M., Vagelos R.H., Fowler M.B., and Ashley E.A. Emerging therapies for the management of decompensated heart failure. From bench to bedside. J Am Coll Cardiol 48 (2006) 2397-2409
6. Shin D.D., Brandimarte F., DeLuca L., et al. Review of current and investigational pharmacologic agents for acute decompensated heart failure. Am J Cardiol 99 Suppl (2007) 4A-23A
7. Mebazaa A. The SURVival of patients with acute heart failure in need of Intra-VEnous inotropic support (SURVIVE) trial (late breaking clinical trials). Paper presented at: American Heart Association Annual Scientific Sessions; November 13-16, 2005; Dallas, TX.
8. Micheletti R., Palazzo F., Barassi P., et al. Istaroximone, a stimulator of sarcoplasmic reticular calcium adenosine triphosphatase isoform 2a activity, as a novel therapeutic approach to heart failure. Am J Cardiol 99 Suppl (2007) 24A-32A
9. Muller O.J., Lange M., Rattunde H., et al. Transgenic rat hearts overexpressing SERCA2a show improved contractility under baseline conditions and pressure overload. Cardiovasc Res 59 (2003) 380-389
10. Sabbah H.N., Imai M., Cowart D., Amato A., Carminati P., and Gheorghiade M. Hemodynamic properties of a new-generation positive luso-inotropic agent for the acute treatment of advanced heart failure. Am J Cardiol 99 Suppl (2007) 41A-46A
11. Adamson P.R., Vanoli E., Matttera G.C., et al. Hemodynamic effects of a new inotropic compound, PST-2744, in dogs with chronic ischemic heart failure. J Cardiovasc Pharmacol 42 (2003) 169-173
12. Gheorghiade M., Blair J.E.A., Filippatos G.S., et al., HORIZON-HF Investigators. Hemodynamic, echocardiographic, and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure. J Am Coll Cardiol 51 (2008) 2276-2285
13. Ghali J.K., Smith W.B., Torre-Amione G., et al. A phase 1-2 dose-escalating study evaluating the safety and tolerability of istaroxime and specific effects on electrocardiographic and hemodynamic parameters in patients with chronic heart failure and reduced systolic function. J Am Coll Cardiol Suppl (2007) 47A-56A
14. Hunt S.A., Abraham W.T., Chin M.H., et al. ACC/AHA 2005 guidelines update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 46 (2005) 1116-1143